Literature DB >> 3621700

Pathophysiology in malignant hypertension: with special reference to the renin-angiotensin system.

N Kawazoe, T Eto, I Abe, S Takishita, M Ueno, K Kobayashi, K Uezono, H Muratani, Y Kimura, Y Tomita.   

Abstract

Pathophysiology of malignant hypertension, of which underlying disease was essential hypertension (EHT) in 33 cases and chronic glomerulonephritis (CGN) in 26 cases, was studied with reference to the renin-angiotensin system. Plasma renin activity (PRA) was significantly higher in the EHT than in the CGN group, and angiotensin II antagonist [Sar1, Ile8]angiotensin II (AIIA) induced a significant lowering of blood pressure only in the former group. PRA was linearly correlated with both pretreatment mean blood pressure (MBP, r = 0.474, n = 29, p less than 0.01) and serum creatinine (r = 0.540, n = 29, p less than 0.01) in the EHT group but not in CGN patients, although there was an inverse correlation between PRA and serum sodium in both groups. Multiple regression analysis revealed that PRA was independently related to MBP, serum creatinine, and serum sodium in the EHT group, but not in the CGN group. These results suggest that the renin-angiotensin system plays a significant role in elevating blood pressure and deteriorating renal function in malignant hypertension derived from EHT, but it is less important in CGN related hypertension.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3621700     DOI: 10.1002/clc.4960100911

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  3 in total

1.  Comparison of effects of enalapril and captopril on serum potassium concentration in the treatment of malignant hypertension.

Authors:  T Tsuchihashi; I Abe; A Tsukashima; K Kobayashi; M Ueno; M Fujishima
Journal:  Cardiovasc Drugs Ther       Date:  1992-10       Impact factor: 3.727

2.  Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats.

Authors:  Šárka Jíchová; Libor Kopkan; Zuzana Husková; Šárka Doleželová; Jan Neckář; Petr Kujal; Zdenka Vernerová; Herbert J Kramer; Janusz Sadowski; Elzbieta Kompanowska-Jezierska; Rami N Reddy; John R Falck; John D Imig; Luděk Červenka
Journal:  J Hypertens       Date:  2016-10       Impact factor: 4.844

3.  Elevated Plasma Renin Activity Caused by Accelerated-malignant Hypertension in a Patient with Aldosterone-producing Adenoma Complicated with Renal Insufficiency.

Authors:  Tatsuya Maruhashi; Michitaka Amioka; Shinji Kishimoto; Hiroki Ikenaga; Kenji Oki; Mari Ishida; Yasuki Kihara; Yukihito Higashi
Journal:  Intern Med       Date:  2019-07-10       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.